Scholars Central

ArticlePublished 2013

New Developments in the Management of Borderline Resectable Pancreatic Cancers

Authors: Muhammad Wasif Saif, Kathryn Huber, Martin D Goodman, Sarah McPartl

Journal of the Pancreas

Volume 14 · Issue 4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

There remains great variability in the treatment for patients with borderline resectable pancreatic head cancers. Whethersurgery should be attempted or neoadjuvant therapy consisting of chemoradiation or chemotherapy alone is at some debate. Each neoadjuvant regimen does show efficacy but there is no clear consensus which would be most beneficial. We will discuss three abstracts (#4043, #4057, #e15082) that were presented in the 2013 ASCO Annual Meeting that will discuss neoadjuvant therapies and how they are related to getting an R0 resection.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of the Pancreas.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of the Pancreas
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Muhammad Wasif Saif”
  • BylineArticles whose byline prints “Kathryn Huber”
  • BylineArticles whose byline prints “Martin D Goodman”
  • BylineArticles whose byline prints “Sarah McPartl”